Quantum Cyber N.V. Par Value Per Share
Quantum Cyber N.V. (QUCY) had Par Value Per Share of $274.00 per share as of 2023-02-15, per its 6-K filed 2025-09-26.
Financial Statements › Notes › Per Share
ifrs-full:ParValuePerShare · last filed 2025-09-26
- 2023-02-15: Par Value Per Share $274.00; Par Value Per Share as first filed $6.85.
- 2021-12-31: Par Value Per Share $0.01.
- 2021-11-30: Par Value Per Share $5.00.
USD/shares
| Period end | Par Value Per Share | Par Value Per Share as first filed |
|---|---|---|
| 2023-02-15 | $274.00 6-K · filed 2025-09-26 | $6.85 20-F · filed 2024-04-09 |
| 2021-12-31 | $0.01 20-F · filed 2022-05-03 | |
| 2021-11-30 | $5.00 20-F · filed 2023-04-07 |
EUR/shares
| Period end | Par Value Per Share |
|---|---|
| 2022-12-31 | 0.01 EUR/shares 20-F · filed 2023-04-07 |
| 2020-12-31 | 1.00 EUR/shares 6-K · filed 2023-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |